Patient Group Direction
A Patient Group Directions (PGDs) must only be used by registered health professionals who have been named and authorised by their organisation to practice under it. The most recent and in-date final signed version of the PGD should be used.
NHS England is responsible for producing and disseminating the NHS Immunisation programme and travel vaccine PGDs.
Practitioners and organisations must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date. Current versions of PHE PGD templates for local authorisation can be found from https://www.gov.uk/government/collections/immunisation and they are also hosted here on the Pan Mersey Area Prescribing Committee website to support any clinician who needs to access the latest version.
Any concerns regarding the content of PGD for the NHS immunisation programme should be addressed to immunisation@phe.gov.uk
Hepatitis A infection: prevention and control guidance
This page contains guidance for the public health management of hepatitis A infection as well as temporary vaccination recommendations in light of an ongoing hepatitis A outbreak primarily affecting men who have sex with men (MSM) and a global shortage of global hepatitis A.
Hepatitis B: vaccine recommendations during supply constraints
Vaccine recommendations for adults and children during periods of vaccine supply constraints
Hepatitis B immunisation recommendations have been developed in light of the recent global shortages of hepatitis B vaccine affecting the UK supply.
These recommendations include advice on prioritisation and dose sparing to preserve adult and paediatric monovalent hepatitis B vaccine stock for those at highest immediate need.
Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTaP/IPV)
Reference: DTaP/IPV PGD
Version: v3.00
Valid from: 1 December 2019
Expiry date: 31 November 2021
Reference: DTaP/IPV/Hib Booster PGD
Version: v01.00
Valid from: 12 September 2017
Expiry date: 31 August 2019
Reference: DTAP/IPV/Hib/HepB PGD
Version: v02.00
Valid from: 01 September 2019
Expiry date: 31 August 2021
Haemophilus influenzae type b and meningococcal C conjugate vaccine (Hib/MenC)
Reference: Hib/MenC PGD
Version: v04.00
Valid from: 1 August 2020
Expiry date: 31 July 2022
Measles, mumps and rubella (MMR) vaccine
Reference: MMR Vaccine PGD
Version: v03.00
Valid from: 1 March 2020
Expiry date: 28 February 2022
Meningococcal group B vaccine (rDNA, component, adsorbed)
Reference: MenB PGD
Version: v04.00
Valid from: 1 March 2019
Expiry date: 28 February 2021
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV)
Reference: PCV PGD
Version: v03.00
Valid from: 26 February 2020
Expiry date: 28 February 2022
Reference: Rotavirus PGD
Version: v04.00
Valid from: 1 July 2019
Expiry date: 30 Jun 2021
Diphtheria, tetanus and inactivated poliomyelitis vaccine, low dose (Td/IPV)
Reference: Td/IPV (Revaxis®) PGD
Version: v03.00
Valid from: 1 November 2019
Expiry date: 31 October 2021
Meningococcal group A, C, W and Y conjugate vaccine (MenACWY)
Reference: MenACWY PGD
Version: v03.00
Valid from: 1 July 2019
Expiry date: 31 Jul 2021
Papillomavirus vaccine, human [Types 6, 11, 16, 18] (Recombinant, adsorbed) (HPV)
Reference: HPV PGD
Version: v03.00
Valid from: 1 May 2019
Expiry date: 31 August 2021
Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV) low dose
Reference: Pertussis PGD
Version: v04.00
Valid from: 1 April 2019
Expiry date: 31 march 2021
Pneumococcal polysaccharide vaccine (PPV)
Reference: PPV PGD
Version: v03.00
Valid from: 1 September 2020
Expiry date: 31 August 2022
Shingles (Herpes zoster, live)
Reference: Shingles PGD
Version: v08.00
Valid from: 1 April 2019
Expiry date: 31 March 2021
Haemophilus influenzae type b and menningococcal C conjugate vaccine
Reference: Hib/MenC Risk Groups PGD
Version: v02.00
Valid from: 1 November 2018
Expiry date: 31 October 2020
Hepatitis A vaccine (adsorbed)
Reference: Hepatitis A vaccine PGD
Version: v03.00
Valid from: 1 November 2019
Expiry date: 31 October 2021
Hepatitis A and Hepatitis B vaccine (adsorbed)
Reference: HepA/B vaccine PGD
Version: v02.00
Valid from: 1 November 2019
Expiry date: 31 October 2021
Hepatitis A and Hepatitis B vaccine (adsorbed) during times of monovalent vaccine shortages
Reference: HepA/B vaccine (Temp) PGD
Version: v02.00
Valid from: 1 November 2018
Expiry date: 31 October 2020
Hepatitis A virus (inactivated) and typhoid polysaccharide vaccine
Reference: HepA/Typhoid vaccine PGD
Version: v02.00
Valid from: 1 March 2020
Expiry date: 28 February 2022
Hepatitis B (rDNA) vaccine (adsorbed) (HepB vaccine)
Reference: HepB PGD
Version: v02.00
Valid from: 1 May 2019
Expiry date: 30 April 2021
Hepatitis B (rDNA) vaccine (adsorbed) (HepB vaccine) for renal patients
Reference: HepB Renal PGD
Version: v02.00
Valid from: 1 May 2019
Expiry date: 30 April 2021
Meningococcal group A, C, W, and Y conjugate vaccine (MenACWY) for risk groups
Reference: MenACWY Risk Groups PGD
Version: v02.00
Valid from: 1 March 2019
Expiry date: 28 February 2021
Meningococcal group B vaccine (rDNA, component, adsorbed) for risk groups
Reference: Men B Risk Groups PGD
Version: v02.00
Valid from: 1 March 2019
Expiry date: 28 February 2021
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV13) for risk groups
Reference: PCV Risk Groups PGD
Version: v04.00
Valid from: 26 February 2020
Expiry date: 28 February 2022
Typhoid Vi polysaccharide vaccine
Reference: Typhoid Vi vaccine PGD
Version: v02.00
Valid from: 1 March 2020
Expiry date: 28 February 2022
Reference: Inactivated Influenza PGD
Version: v08.00
Valid from: 1 September 2020
Expiry date: 31 March 2021
Live attenuated influenza vaccine nasal spray suspension
Reference: LAIV PGD
Version: v09.00
Valid from: 1 September 2020
Expiry date: 31 March 2021